REUTERS - Swiss pharmaceutical manufacturer Lonza Group AG on Monday confirmed it is in advanced talks with private equity firm KKR & Co LP to acquire Capsugel, a U.S. maker of capsule products and ...

Private equity firm KKR will buy Pfizer’s Capsugel business for $2.375 billion in cash, the firms revealed Monday morning in a joint statement. Capsugel generated about $750 million in revenue in 2010 ...

Xcelience provides the company with specialized clinical trial manufacturing and supply capabilities for a broad range of solid dosage forms Powdersize brings micronization capabilities that augment ...

Lonza Group, a Swiss chemicals and biotechnology company, will acquire Capsugel for $5.5 billion, reports Reuters. Here are four things to know about the deal. 1. Capsugel, based in Morristown, N.J., ...

NEW YORK -- Pfizer Inc. said Monday it will sell its Capsugel capsule-making business to private equity firm Kohlberg Kravis Robert & Co. for $2.38 billion in cash. In October, Pfizer said it would ...

Capsugel and Monash University announced today that Capsugel has acquired the intellectual property pertaining to proprietary Ionic Liquids Technology developed at the Monash Institute of ...

I was going to title this post "Big or Small We Track Them All" but on second thought it seemed too wordy and just a little bit confusing. Pharmaceutical giant Pfizer (PFE) announced today that it is ...

Capsugel adds clinical trial and commercial manufacturing, as well as particle engineering services with two acquisitions. In the latest development in a busy year of mergers and acquisitions in the ...